Kit For The Preparation Of Indium In 111 Pentetreotide Kit
Product Images NDC 45567-0755

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Kit For The Preparation Of Indium In 111 Pentetreotide (NDC 45567-0755). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Pentetreotide 01)

This text appears to be a chemical structure representing a peptide molecule. It contains various amino acids such as D-Phe, Cys, Phe, D-Trp, Lys, Thr, and others. The structure includes bonds between the amino acids denoted by specific symbols.*

FDA Label Image

Pdp-01 (Pentetreotide 02)

FDA Label Image

Pdp-02 (Pentetreotide 03)

This is a description of a refrigerated kit for the preparation of Indium In 111 Pentetreotide Injection. The kit is stored refrigerated and shielded from light. It contains sterile and non-pyrogenic components for use with Indium In 111 Chloride Solution. The kit includes a radioassay information table, injection needles, and other necessary components. Prior to use, sodium hydroxide or hydrochloric acid may be added for pH adjustment. The kit is manufactured by Sun Pharmaceutical Industries, Inc.*

FDA Label Image

Pdp-03 (Pentetreotide 04)

Kit for the Preparation of Indium In 111 Pentetreotide Injection. This kit includes a reaction vial containing sterile, non-pyrogenic ingredients for intravenous administration after drug preparation. The contents of the vial include pentetreotide, gentisic acid, sodium citrate, citric acid, and inositol. Prior to lyophilization, sodium hydroxide or hydrochloric acid can be added for pH adjustment. The pH of the reconstituted solution is between 3.8 and 4.3. The kit is manufactured by Sun Pharmaceutical Industries, Inc. and must be stored refrigerated. It is advised to protect from light and use only with Indium 111 Chloride Solution.*

FDA Label Image

Pdp-04 (Pentetreotide 05)

This text appears to be detailing the usage instructions and composition of a radioactive drug called Indium In-111 Chloride. The drug is meant for intravenous use and requires preparation before administration. The solution is stored at or below 25°C and contains specific amounts of indium In-111, ferric chloride, and hydrochloric acid. The vial size is 11 mL with a concentration of 111 MBq/mL. It is important to follow the package insert for proper usage directions.*

FDA Label Image

Pdp-05 (Pentetreotide 06)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.